Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin B is a key regulatory protein involved in the control of the cell cycle, specifically governing entry into and exit from mitosis (M phase). It functions primarily by forming a complex with cyclin-dependent kinase 1 (CDK1), also known as p34(cdc2), to create the maturation-promoting factor (MPF). Its degradation is required for exit from mitosis via ubiquitination mediated by the anaphase-promoting complex/cyclosome (APC/C), which targets cyclin B for proteasomal degradation. Overexpression or dysregulation of cyclin B has been observed in various cancers and correlates with tumor aggressiveness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin B.